Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Amicus Therapeutics (FOLD) Long-Term Debt Issuances (2016 - 2018)

Amicus Therapeutics (FOLD) has disclosed Long-Term Debt Issuances for 6 consecutive years, with -$26000.0 as the latest value for Q4 2018.

  • For the quarter ending Q4 2018, Long-Term Debt Issuances changed N/A year-over-year to -$26000.0, compared with a TTM value of -$26000.0 through Dec 2021, changed 0.0%, and an annual FY2023 reading of $387.4 million, changed N/A over the prior year.
  • Long-Term Debt Issuances was -$26000.0 for Q4 2018 at Amicus Therapeutics, down from $212.5 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $212.5 million in Q4 2016 and bottomed at -$26000.0 in Q4 2018.
  • Average Long-Term Debt Issuances over 3 years is $77.4 million, with a median of $19.6 million recorded in 2014.
  • Peak annual rise in Long-Term Debt Issuances hit 292.82% in 2014, while the deepest fall reached 292.82% in 2014.
  • Year by year, Long-Term Debt Issuances stood at $19.6 million in 2014, then skyrocketed by 982.1% to $212.5 million in 2016, then tumbled by 100.01% to -$26000.0 in 2018.
  • Business Quant data shows Long-Term Debt Issuances for FOLD at -$26000.0 in Q4 2018, $212.5 million in Q4 2016, and $19.6 million in Q1 2014.